20 May 2013
Keywords: pdl, shares, plunge, firm, ends, sale, process
Article | 17 March 2008
Shares in PDL BioPharma plunged 32%, after the US biotechnology firm
decided to take itself off the market (Marketletters passim). Although
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 October 2007
17 May 2013
© 2013 thepharmaletter.com